48.10
BATS BZX Real-Time Price
As of 11:32am ET
 +0.15 / +0.31%
Today’s Change
10.05
Today|||52-Week Range
48.25
+20.10%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.3B

Company Description

Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Contact Information

Zogenix, Inc.
5858 Horton Street
Emeryville California 94608
P:(510) 550-8300
Investor Relations:

Employees

Shareholders

Other institutional66.26%
Mutual fund holders36.38%
Individual stakeholders13.92%

Top Executives

Stephen J. FarrPresident, Chief Executive Officer & Director
Michael P. SmithCFO, Secretary, Treasurer & Executive VP
Bradley S. GalerChief Medical Officer & Executive Vice President
Steven A. JohnsonVice President & Compliance Officer
Gail M. FarfelChief Development Officer & Executive VP